IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.
about
Conversion from cyclosporine to FK 506 in liver allograft recipients with cyclosporine-related complications.Allograft and xenograft acceptance under FK-506 and other immunosuppressant treatment.Cytomegalovirus infection of the upper gastrointestinal tract following liver transplantation--incidence, location, and severity in cyclosporine- and FK506-treated patients.Effect of FK506 in experimental organ transplantation.Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyAIncidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506.Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506.Suppression of allograft rejection with FK506. I. Prolonged cardiac and liver survival in rats following short-course therapy.The effect of FK 506 and CyA on the Lewis rat renal ischemia model.In Vitro Immunosuppressive Effects of FK506 in Combination With Other DrugsIMMUNOSUPPRESSION WITH FR 900506 FOR CANINE KIDNEY AND LIVER TRANSPLANTATION.Increased cyclosporine uptake by cells pretreated with FK506 and evidence for binding of both drugs to a common intracellular protein.FK506: a novel immunosuppressive agent. Characteristics of binding and uptake by human lymphocytes.Differential survival of hamster-to-rat liver and cardiac xenografts under FK 506 immunosuppression.
P2860
Q33993513-76826095-5433-4125-97E2-B0EFCCE62CB5Q34178489-755EC645-7558-4C7C-B494-13880840CB20Q34232708-F196C5D9-7758-48A3-96FD-0B3A3E236054Q34248795-3714253F-953A-47BA-95AD-4ADF2F788130Q34257082-5C7E7667-32AB-4474-ADF2-B57899127D72Q34257382-AC78D4AA-DEBB-4780-BF64-089355BF473AQ34275070-10672D73-FCDE-4E8B-B914-E31F647FE21DQ34280890-21692A73-C107-4463-894F-B4B620AAC7FEQ34298815-92E2A6E8-38D8-4BC0-9FDB-D8D17B5E7AFDQ34414927-20E7EED1-B9C6-47F9-84D9-958BA93940B2Q34555218-4E1662BD-7F09-4BF7-A075-267627C84526Q34942463-9CCC0D6E-393E-45FE-B1DA-28F370B8AD9DQ42090615-43F87BBB-A3B8-48ED-A8F3-458A4B8C8BD9Q42123192-4AE78409-F9D8-47B2-801A-A24CB7178A73Q42579096-CD933543-AAFB-44E0-897A-3F97041E7087
P2860
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.
description
1987 nî lūn-bûn
@nan
1987 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
name
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.
@ast
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.
@en
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.
@nl
type
label
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.
@ast
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.
@en
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.
@nl
prefLabel
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.
@ast
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.
@en
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.
@nl
P2093
P2860
P1476
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION
@en
P2093
P2860
P304
P577
1987-01-01T00:00:00Z